LAG3 and neoplasm: Once bound to MHC II, the cytoplasmic domains of LAG-3 propagate inhibitory signals in CD4+ T lymphocytes, leading to its inactivation and the escape of tumor cells from undergoing immune cell-mediated apoptosis [91].